Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Heart Journal|May 9, 2025
Effect of once-weekly subcutaneous semaglutide on arterial inflammation in people with type 2 diabetes and cardiovascular disease using PET-MRI: Primary results of a randomized, double-blind, placebo-controlled trialStefan James, Andreas Dyreborg Christoffersen, Jens-Peter David, et al.
European Heart Journal. Cardiovascular Imaging|September 15, 2020
Relationship between arterial remodelling and serial changes in coronary atherosclerosis by intravascular ultrasound: an analysis of the IBIS-4 studyKonstantinos C Koskinas, Rafaela Maldonado, Hector M Garcia-Garcia, et al.
The Lancet. Diabetes & Endocrinology|February 4, 2024
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trialMichael J Koren, Olivier Descamps, Yoshiki Hata, et al.
JAMA|April 3, 2022
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical TrialLorenz Räber, Yasushi Ueki, Tatsuhiko Otsuka, et al.
Pageof 1